Ebola Vaccine Looks Promising in Early Trial

US may gain lung disease vaccine through improved relations with Cuba | Athensnews | redandblack.com - Health Council

“The trials involved two candidate Ebola vaccines that were given to volunteers in separate shots, the researchers said. One vaccine was provided first as a “primer” shot, and the second was given as a “booster”. The winning combo was a “primer” shot of a genetically engineered cold virus (AD-26), followed by a “booster” shot of a similarly altered smallpox virus (MVA), according to the report.”

Read the full article: Two-Step Ebola Vaccine Strategy Works in Early Trial